Factors associated with failure to complete adjuvant chemotherapy in pancreatic cancer
Authors:
- 1 April 2016
- journal article
- Published by Elsevier in The American Journal of Surgery
- Vol. 211 (4) , 787-792
Abstract
No abstract availableKeywords
Funding Information
- Nara Medical University
This publication has 29 references indexed in Scilit:
- Evolution of the Whipple procedure at the Massachusetts General HospitalSurgery, 2012
- A randomised phase III trial comparing gemcitabine with surgery-only in patients with resected pancreatic cancer: Japanese Study Group of Adjuvant Therapy for Pancreatic CancerBritish Journal of Cancer, 2009
- Pancreatic Adenocarcinoma: The Actual 5-Year SurvivorsJournal of Gastrointestinal Surgery, 2008
- Long-Term Survival After Pancreatoduodenectomy for Pancreatic AdenocarcinomaAnnals of Surgery, 2008
- Adjuvant Chemotherapy With Gemcitabine vs Observation in Patients Undergoing Curative-Intent Resection of Pancreatic CancerJAMA, 2007
- Pancreatic cancer: surgery alone is not sufficientSurgical Endoscopy, 2006
- PancreaticoduodenectomyArchives of Surgery, 2004
- Pancreaticoduodenectomy with En Bloc Portal Vein Resection for Pancreatic Carcinoma with Suspected Portal Vein InvolvementWorld Journal of Surgery, 2004
- Pancreatic cancerThe Lancet, 2004
- Six Hundred Fifty Consecutive Pancreaticoduodenectomies in the 1990sAnnals of Surgery, 1997